Full text is available at the source.
Abstract
Fecal microbiota transplantation (FMT) may have potential benefits for patients with Parkinson's disease.
- Parkinson's disease is associated with gut-brain axis dysfunction.
- FMT is a microbiome-targeted intervention that could impact PD outcomes.
- Preliminary clinical evidence suggests potential effects of FMT on motor, non-motor, and cognitive functions.
- Randomized clinical evidence on the effectiveness of FMT in PD remains limited.
Simplified
Gut-Brain Axis